Categories Technology

Cognizant is hell-bent on tapping the US healthcare sector, will buy Bolder Healthcare

Healthcare seems to be the keyword for tech companies these days, with most including Apple bringing out products and services to improve the longevity of mankind (God, save our users!).  IT-services major Cognizant is now expanding its reach into the healthcare sector with its intention to acquire Bolder Healthcare Solutions.

Bolder is a private firm that offers revenue cycle management solutions to hospitals and specialty care providers. Through this transaction, which is expected to close in the second quarter of the year, Cognizant plans to expand its services to more hospitals and healthcare providers.

Bolder acquisition will create value for all the shareholders, as a report from Zion Market Research indicated,  the global revenue cycle management is expected to grow to around $43.80 billion by 2022 from $23.40 billion in 2016. Also, a major chunk of the market share is expected to come from North America, which poses an enormous advantage for Cognizant as over 70% of its revenue is derived from this region.

IT-services major Cognizant is now expanding its reach into the healthcare sector with its intention to acquire Bolder Healthcare Solutions. 

Cognizant derives most of its revenue from two industries: Financial services and healthcare business. Over the past few years, Cognizant has been pretty serious with its healthcare business, as it accounts for almost 30% of the company’s total revenue. In the latest fourth quarter, the company reported 12% growth in its revenue from healthcare business.

Cognizant’s largest healthcare deal occurred in 2014 when the company purchased TriZetto for $2.7 billion, which was followed by the acquisition of TMG Health.

Most Popular

CL Earnings: Key quarterly highlights from Colgate-Palmolive’s Q2 2024 financial results

Colgate-Palmolive Company (NYSE: CL) reported its second quarter 2024 earnings results today. Net sales increased 4.9% year-over-year to $5 billion. Organic sales increased 9%. Net income attributable to Colgate-Palmolive Company was $731

Key takeaways from Visa’s Q3 2024 earnings report

Credit card behemoth Visa, Inc. (NYSE: V) this week reported mixed results for the June quarter, with earnings matching expectations and sales slightly missing the view. Both numbers grew in

Southwest Airlines (LUV): A look at the airline’s performance in Q2 2024

Shares of Southwest Airlines Co. (NYSE: LUV) were up over 6% on Thursday after the company beat earnings estimates for the second quarter of 2024. The stock has gained 4%

Tags

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top